mFOLFIRINOX adjuvant chemotherapy Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: 5-Fluorouracil, Irinotecan, Leucovorin, Oxaliplatin

Pipeline

Early 1: 1Phase 3: 1

Top Sponsors

SONIRE Therapeutics Inc.1
Fudan University1

Indications

Cancer2
High-risk Stage II Colorectal Cancer1
Stage III Colorectal Cancer1
Circulating Tumor DNA Methylation1
Pancreatic Cancer1

Other1 trial

Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

Phase 3

San Francisco, California1 trial

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Stanford University

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.